[1] 马建辉.肾细胞癌诊断治疗指南[M].北京:人民卫生出版社,2006: 37-38.[2] Tokuda N, Naito S, Matsuzaki O, et al. Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan[J]. J Urol, 2006, 176(1): 40-43.[3] Karakiewicz P I, Trinh Q D, Rioux-Leclercq N, et al.Collecting duct renal cell carcinoma: a matched analysis of 41 cases[J]. Eur Urol, 2007, 52(4):1140-1145.[4] 孔祥田,曾荔,宓培,等.肾集合管癌的临床病理研究[J].中华外科杂志, 2000, 38(9):719.[5] Yousef G M, Ejeckam G C, Best L M, et al. Collecting duct carcinoma associated with oncocytoma[J]. Int Braz J Urol, 2005, 31 (5): 465-467.[6] Matei D V, Rocco B, Varela R, et al. Synchronous collecting duct carcinoma and papillary renal cell carcinoma: a case report and review of the literature[J]. Anticancer Res, 2005, 25 (1B): 579-586.[7] 孔祥田,曾荔,宓培,等.肾集合管癌10 例分析[J].中华肿瘤杂志,2001,23(2):162-164.[8] Ansari J, Fatima A, Chaudhri S, et al. Sorafenib induces therapeutic response in a patient with metastatic collecting duct carcinoma of kidney[J]. Onkologie, 2009, 32(1-2):44-46.[9] Miyake H, Haraguchi T, Takenaka A, et al. Metastatic collecting duct carcinoma of the kidney responded to sunitinib[J]. Int J Clin Oncol, 2011,16(2):153-155.[10] Bagrodia A, Gold R, Handorf C, et al. Salvage paclitaxel chemotherapy for metastatic collecting duct carcinoma of the kidney[J]. Can J Urol, 2008, 15(6):4425-4427.[11] 迟强,于满,王志勇,等.保留肾单位手术治疗双肾细胞癌十例临床分析[J].中华肿瘤防治杂志,2012,19(22):1745-1747,1760.[12] 张慕淳,张赟,王金辉,等.微血管计数和侵入在肾细胞癌中的表达及意义[J].中国医科大学学报,2011,40(9):794--796.[13] Vázquez-Lavista L G, Uribe-Uribe N, Gabilondo-Navarro F.Collecting duct renal cell carcinoma: two different clinical stages, two different clinical outcomes[J]. Urol Int, 2008, 81(1):116-118.[14] Pepek J M, Johnstone P A, Jani A B. Influence of demographic factors on outcome of collecting duct carcinoma: a Surveillance, Epidemiology, and End Results (SEER) database analysis[J].Clin Genitourin Cancer, 2009, 7(2): E24-27.[15] 朱庆强,王中秋,朱文荣,等. 肾集合管癌的多层螺旋CT诊断[J]. 中华医学杂志,2012, 92(27):1922-1925. |